Reports and Briefs on Pharmaceuticals

Published within

« | ... | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ... | » »|

Type Product title / description Pub Price
Report
Report

Biosimilars: China Update

Biosimilars: China Update provides analysis on the Chinese biogenerics market. It includes an overview of drivers and resistors to biogeneric uptake, market access strategies, key biogeneric players and future development trends.

Published By Datamonitor
22 Sep 2011 $1520
Buy
Report
Report

Emerging Technologies: New Antibody-Based Technologies

Introduction to an emerging class of therapies in the high-growth therapeutic monoclonal antibody sector. Assessment of the sector's key technologies, players and products over the period 2010-16.

Published By Datamonitor
29 Sep 2011 $2800
Buy
Report
Report

Human Genome Sciences, Inc.: PharmaVitae Report

This report analyzes HGS's corporate strategy, sales outlook and financial position through to 2016, supported by in-depth analysis of the company’s key products, driven by patient-based forecasts and key opinion leader interviews.

Published By Datamonitor
13 Oct 2011 $2800
Buy
Report
Report

Biosimilars: India Update

Biosimilars: India Update provides analysis on the Indian copy biologics market. It includes an overview of drivers and resistors to biologic uptake, market access strategies, key domestic biologic players and future development trends.

Published By Datamonitor
14 Oct 2011 $1520
Buy
Report
Report

Otsuka Pharmaceutical Co., Ltd: PharmaVitae Report

Analysis of Otsuka's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
19 Oct 2011 $2800
Buy
Report
Report

Actelion Ltd: PharmaVitae Report

Analysis of Actelion's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
20 Oct 2011 $2800
Buy
Report
Report

Gilead Sciences Inc.: PharmaVitae Report

Analysis of Gilead's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
20 Oct 2011 $2800
Buy
Report
Report

5EU: Pricing, Reimbursement and Regulatory Update

Datamonitor’s report 5EU: Pricing, Reimbursement, and Regulatory Update provides an overview of developments regarding healthcare reforms, drug regulation, and drug pricing and reimbursement in France, Germany, Italy, Spain, and the UK.

Published By Datamonitor
28 Oct 2011 $1520
Buy
Report
Report

Monoclonal Antibodies: 2011

Historical and forecast analysis of the monoclonal antibodies sector from 2004 through to 2016.

Published By Datamonitor
31 Oct 2011 $2800
Buy
Report
Report

Canada: Generics and Biosimilars Overview

Overview of the generics and biosimilars landscape including, regulatory issues, drivers and resistors to uptake, level of penetration, and key players operating in the market.

Published By Datamonitor
03 Nov 2011 $1520
Buy

« | ... | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ... | » »|

No help is available.